Adverse ophthalmic reactions associated with poppers use


Users of poppers have experienced visual impairment and maculopathy in a UK case series

Though poppers have been considered by scientific experts to present a low risk to physical and mental health, there have been reports of 'poppers maculopathy' since 2007, when (due to legislative changes) the most commonly used compound in poppers was changed from isobutyl nitrite to isopropyl nitrite.

Clinical issues observed

Of the seven patients included in the series, two had used poppers regularly over a period of 20 and 14 years and had begun to notice visual impairment over the preceding two years, while the remaining five patients each reported taking the substances for the first or only time within the previous two weeks. The habitual poppers users took longer to diagnose (median: 16 months) and presented with more severe initial symptoms compared with first- or one-time users.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.